Explore jobs
Find specific jobs
Explore careers
Explore professions
Best companies
Explore companies
MAP Pharmaceuticals history
MAP Pharmaceuticals company history timeline
2005 Sanborn announces the acquisition of Space Imaging's North American Federal Civil and Commercial Solutions business unit.
2010 – MAP provides more than $20 million in disaster aid following a devastating earthquake that leveled Port Au Prince, Haiti.
2017 - Through the generosity of thousands of donors, MAP provides Disaster Health Kits, medicines and other relief supplies to people in Texas following Hurricane Harvey, Florida and Georgia following Hurricane Irma and Puerto Rico and Dominica following Hurricane Maria.
2018 - GuideStar, the world's largest source for information about non-profit organizations, awards MAP International its Platinum Seal of Transparency.
Kroll remains distinct from the database-driven mapping that is commonly seen in digital device-created maps, in that each element has been carefully crafted and authored for a "static view" (Loacker email, March 9, 2020).
Among products the company produced as of 2020 were maps for Seattle City Light (including showing new easements), maps for book publications, custom large-format wall maps, maps displaying demographics, and other maps customized for clients.
Rate how well MAP Pharmaceuticals lives up to its initial vision.
MAP Pharmaceuticals jobs
Do you work at MAP Pharmaceuticals?
Is MAP Pharmaceuticals' vision a big part of strategic planning?
MAP Pharmaceuticals competitors
| Company name | Founded date | Revenue | Employee size | Job openings |
|---|---|---|---|---|
| Adamis Pharmaceuticals | 2006 | $4.8M | 131 | - |
| Satsuma Pharmaceuticals | 2016 | $492.9M | 5 | 6 |
| Pulmatrix | 2003 | $7.8M | 22 | - |
| Seelos Therapeutics | 2016 | $375,000 | 10 | - |
| Apellis Pharmaceuticals | 2008 | $781.4M | 200 | - |
| Civitas Therapeutics | 2009 | $72.9M | 20 | 7 |
| Delcath Systems | 1987 | $37.2M | 36 | 6 |
| Hoffmann-LA Roche Inc | 1896 | $60.9B | 101,200 | 105 |
| PTC Therapeutics | 1998 | $806.8M | 517 | 9 |
| Ariad Pharmaceuticals | 1991 | $118.8M | 380 | - |
MAP Pharmaceuticals history FAQs
Zippia gives an in-depth look into the details of MAP Pharmaceuticals, including salaries, political affiliations, employee data, and more, in order to inform job seekers about MAP Pharmaceuticals. The employee data is based on information from people who have self-reported their past or current employments at MAP Pharmaceuticals. The data on this page is also based on data sources collected from public and open data sources on the Internet and other locations, as well as proprietary data we licensed from other companies. Sources of data may include, but are not limited to, the BLS, company filings, estimates based on those filings, H1B filings, and other public and private datasets. While we have made attempts to ensure that the information displayed are correct, Zippia is not responsible for any errors or omissions or for the results obtained from the use of this information. None of the information on this page has been provided or approved by MAP Pharmaceuticals. The data presented on this page does not represent the view of MAP Pharmaceuticals and its employees or that of Zippia.
MAP Pharmaceuticals may also be known as or be related to MAP PHARMACEUTICALS, INC., MAP Pharmaceuticals and Map Pharmaceuticals.